High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. Oxombre B, Lee-Chang C, Duhamel A, Toussaint M, Giroux M, Donnier-Marechal M, Carato P, Lefranc D, Zephir H, Prin L, Melnyk P, & Vermersch P Br. J. Pharmacol., 172:1769-1782, 2015.
Paper doi bibtex @article{oxombre_b_high-affinity_2015,
title = {High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis},
volume = {172},
issn = {0007-1188},
url = {http://www.ncbi.nlm.nih.gov/pubmed/25521311},
DOI = {10.1111/bph.13037},
Language = {English},
Journal = {Br. J. Pharmacol.},
author = {{Oxombre B} and {Lee-Chang C} and {Duhamel A} and {Toussaint M} and {Giroux M} and {Donnier-Marechal M} and {Carato P} and {Lefranc D} and {Zephir H} and {Prin L} and {Melnyk P} and {Vermersch P}},
year = {2015},
keywords = {Animals, B-Lymphocytes/immunology, Brain/drug effects, Brain/pathology, Cytokines/blood, Encephalomyelitis, Autoimmune, Experimental/blood, Encephalomyelitis, Autoimmune, Experimental/drug therapy*, Encephalomyelitis, Autoimmune, Experimental/immunology, Encephalomyelitis, Autoimmune, Experimental/pathology, Female, Immunoglobulin G/blood, Lymph Nodes/drug effects, Lymph Nodes/immunology, Mice, Multiple Sclerosis/blood, Multiple Sclerosis/drug therapy*, Multiple Sclerosis/immunology, Multiple Sclerosis/pathology, Myelin Proteolipid Protein/immunology, Neuroprotective Agents/pharmacology, Neuroprotective Agents/therapeutic use*, Peptide Fragments/immunology, Receptors, sigma/agonists*, Spinal Cord/drug effects, Spinal Cord/pathology, Spleen/drug effects, Spleen/immunology, T-Lymphocytes, Regulatory/immunology},
pages = {1769-1782}
}
Downloads: 0
{"_id":"wNygNYJYkeouEYEja","bibbaseid":"oxombreb-leechangc-duhamela-toussaintm-girouxm-donniermarechalm-caratop-lefrancd-etal-highaffinitysigma1proteinagonistreducesclinicalandpathologicalsignsofexperimentalautoimmuneencephalomyelitis-2015","authorIDs":[],"author_short":["Oxombre B","Lee-Chang C","Duhamel A","Toussaint M","Giroux M","Donnier-Marechal M","Carato P","Lefranc D","Zephir H","Prin L","Melnyk P","Vermersch P"],"bibdata":{"bibtype":"article","type":"article","title":"High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis","volume":"172","issn":"0007-1188","url":"http://www.ncbi.nlm.nih.gov/pubmed/25521311","doi":"10.1111/bph.13037","language":"English","journal":"Br. J. Pharmacol.","author":[{"firstnames":[],"propositions":[],"lastnames":["Oxombre B"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Lee-Chang C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Toussaint M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Giroux M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Donnier-Marechal M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Carato P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Lefranc D"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Zephir H"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Prin L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Melnyk P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Vermersch P"],"suffixes":[]}],"year":"2015","keywords":"Animals, B-Lymphocytes/immunology, Brain/drug effects, Brain/pathology, Cytokines/blood, Encephalomyelitis, Autoimmune, Experimental/blood, Encephalomyelitis, Autoimmune, Experimental/drug therapy*, Encephalomyelitis, Autoimmune, Experimental/immunology, Encephalomyelitis, Autoimmune, Experimental/pathology, Female, Immunoglobulin G/blood, Lymph Nodes/drug effects, Lymph Nodes/immunology, Mice, Multiple Sclerosis/blood, Multiple Sclerosis/drug therapy*, Multiple Sclerosis/immunology, Multiple Sclerosis/pathology, Myelin Proteolipid Protein/immunology, Neuroprotective Agents/pharmacology, Neuroprotective Agents/therapeutic use*, Peptide Fragments/immunology, Receptors, sigma/agonists*, Spinal Cord/drug effects, Spinal Cord/pathology, Spleen/drug effects, Spleen/immunology, T-Lymphocytes, Regulatory/immunology","pages":"1769-1782","bibtex":"@article{oxombre_b_high-affinity_2015,\r\ntitle = {High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis},\r\nvolume = {172},\r\nissn = {0007-1188},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/25521311},\r\nDOI = {10.1111/bph.13037},\r\nLanguage = {English},\r\nJournal = {Br. J. Pharmacol.},\r\nauthor = {{Oxombre B} and {Lee-Chang C} and {Duhamel A} and {Toussaint M} and {Giroux M} and {Donnier-Marechal M} and {Carato P} and {Lefranc D} and {Zephir H} and {Prin L} and {Melnyk P} and {Vermersch P}},\r\nyear = {2015},\r\nkeywords = {Animals, B-Lymphocytes/immunology, Brain/drug effects, Brain/pathology, Cytokines/blood, Encephalomyelitis, Autoimmune, Experimental/blood, Encephalomyelitis, Autoimmune, Experimental/drug therapy*, Encephalomyelitis, Autoimmune, Experimental/immunology, Encephalomyelitis, Autoimmune, Experimental/pathology, Female, Immunoglobulin G/blood, Lymph Nodes/drug effects, Lymph Nodes/immunology, Mice, Multiple Sclerosis/blood, Multiple Sclerosis/drug therapy*, Multiple Sclerosis/immunology, Multiple Sclerosis/pathology, Myelin Proteolipid Protein/immunology, Neuroprotective Agents/pharmacology, Neuroprotective Agents/therapeutic use*, Peptide Fragments/immunology, Receptors, sigma/agonists*, Spinal Cord/drug effects, Spinal Cord/pathology, Spleen/drug effects, Spleen/immunology, T-Lymphocytes, Regulatory/immunology},\r\npages = {1769-1782}\r\n}\r\n\r\n","author_short":["Oxombre B","Lee-Chang C","Duhamel A","Toussaint M","Giroux M","Donnier-Marechal M","Carato P","Lefranc D","Zephir H","Prin L","Melnyk P","Vermersch P"],"key":"oxombre_b_high-affinity_2015","id":"oxombre_b_high-affinity_2015","bibbaseid":"oxombreb-leechangc-duhamela-toussaintm-girouxm-donniermarechalm-caratop-lefrancd-etal-highaffinitysigma1proteinagonistreducesclinicalandpathologicalsignsofexperimentalautoimmuneencephalomyelitis-2015","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/25521311"},"keyword":["Animals","B-Lymphocytes/immunology","Brain/drug effects","Brain/pathology","Cytokines/blood","Encephalomyelitis","Autoimmune","Experimental/blood","Encephalomyelitis","Autoimmune","Experimental/drug therapy*","Encephalomyelitis","Autoimmune","Experimental/immunology","Encephalomyelitis","Autoimmune","Experimental/pathology","Female","Immunoglobulin G/blood","Lymph Nodes/drug effects","Lymph Nodes/immunology","Mice","Multiple Sclerosis/blood","Multiple Sclerosis/drug therapy*","Multiple Sclerosis/immunology","Multiple Sclerosis/pathology","Myelin Proteolipid Protein/immunology","Neuroprotective Agents/pharmacology","Neuroprotective Agents/therapeutic use*","Peptide Fragments/immunology","Receptors","sigma/agonists*","Spinal Cord/drug effects","Spinal Cord/pathology","Spleen/drug effects","Spleen/immunology","T-Lymphocytes","Regulatory/immunology"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:55.021Z","downloads":0,"keywords":["animals","b-lymphocytes/immunology","brain/drug effects","brain/pathology","cytokines/blood","encephalomyelitis","autoimmune","experimental/blood","encephalomyelitis","autoimmune","experimental/drug therapy*","encephalomyelitis","autoimmune","experimental/immunology","encephalomyelitis","autoimmune","experimental/pathology","female","immunoglobulin g/blood","lymph nodes/drug effects","lymph nodes/immunology","mice","multiple sclerosis/blood","multiple sclerosis/drug therapy*","multiple sclerosis/immunology","multiple sclerosis/pathology","myelin proteolipid protein/immunology","neuroprotective agents/pharmacology","neuroprotective agents/therapeutic use*","peptide fragments/immunology","receptors","sigma/agonists*","spinal cord/drug effects","spinal cord/pathology","spleen/drug effects","spleen/immunology","t-lymphocytes","regulatory/immunology"],"search_terms":["high","affinity","sigma","protein","agonist","reduces","clinical","pathological","signs","experimental","autoimmune","encephalomyelitis","oxombre b","lee-chang c","duhamel a","toussaint m","giroux m","donnier-marechal m","carato p","lefranc d","zephir h","prin l","melnyk p","vermersch p"],"title":"High-affinity sigma 1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis","year":2015,"dataSources":["Tt6zYqvN5kE3wbwiR"]}